Potential future therapies for haemophilia
The haemophilias are disorders that affect the blood clotting system. Roughly 85% of haemophilia sufferers are affected by haemophilia A this translates into roughly 1 in 5000 males. Haemophilia B affects roughly 1 in 30,000 male. Haemophilia is a disease which has been in the spotlight in recent years due to it being an ideal candidate for gene therapy. Some have stated that if gene therapy cannot be implemented with haemophilia it is unlikely to work in other diseases.
Research into a number of future therapies to aid treatment of haemophilia suffers has yielded good results. Certain future treatments such as gene therapy if successful in haemophilia could pave the way for treatment of other diseases.
